Open AccessNon-alcoholic fatty liver disease later diagnosed as myotonic dystrophy
Author(s) -
Naoki Tanaka,
Takefumi Kimura,
Naoyuki Fujimori,
Yasuyuki Ichise,
Kenji Sakai,
Akira Horiuchi
Publication year - 2020
Publication title -
world journal of hepatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v12.i9.685
Subject(s) - medicine , fatty liver , steatohepatitis , gastroenterology , liver biopsy , dyslipidemia , steatosis , myopathy , muscle biopsy , pathology , endocrinology , disease , biopsy
Myotonic dystrophy (MD) is sometimes accompanied by metabolic/endocrine disorders, including dyslipidemia, central obesity, and hypogonadism. Due to considerable individual differences in the severity and progression of myopathy, MD patients with minimal-to-mild muscle symptoms might be followed as having other diseases, such as non-alcoholic fatty liver disease (NAFLD).